Eric Lefebvre Pliant Therapeutics, Inc. (PLRX) insider trading activity

Eric Lefebvre is Chief Medical Officer of PLIANT THERAPEUTICS, INC.. Currently has a direct ownership of 240,224 shares of PLRX, which is worth approximately $2.58 Million. The most recent transaction as insider was on Jan 23, 2025, when has been sold 45,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 240K

12.75% 3M change

20.22% 12M change

Total Value Held $2.58 Million

Eric Lefebvre Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 23 2025	BUY Grant, award, or other acquisition	-	45,650 Added 15.97%	240,224 Common Stock
Jan 17 2025	SELL Open market or private sale	$206,953 $11.2 p/Share	18,478 Reduced 8.67%	194,574 Common Stock
Jul 10 2024	SELL Open market or private sale	$142,407 $11.56 p/Share	12,319 Reduced 5.47%	213,052 Common Stock
Jul 09 2024	BUY Grant, award, or other acquisition	-	24,063 Added 9.65%	225,371 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	42,900 Added 17.67%	199,820 Common Stock
Jan 17 2024	SELL Open market or private sale	$177,382 $17.23 p/Share	10,295 Reduced 6.16%	156,920 Common Stock
Jul 17 2023	SELL Open market or private sale	$402,001 $18.01 p/Share	22,321 Reduced 11.78%	167,215 Common Stock
Jul 14 2023	BUY Grant, award, or other acquisition	-	43,750 Added 18.75%	189,536 Common Stock
Mar 30 2023	SELL Open market or private sale	$298,217 $26.52 p/Share	11,245 Reduced 7.16%	145,786 Common Stock
Mar 29 2023	BUY Grant, award, or other acquisition	-	21,874 Added 12.23%	157,031 Common Stock
Jan 25 2023	BUY Grant, award, or other acquisition	-	57,000 Added 29.85%	133,926 Common Stock
Jan 23 2023	SELL Open market or private sale	$2,327,400 $34.48 p/Share	67,500 Reduced 46.74%	76,926 Common Stock
Dec 20 2022	SELL Open market or private sale	$207,941 $19.1 p/Share	10,887 Reduced 7.01%	144,426 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	21,876 Added 12.35%	155,313 Common Stock
Oct 25 2022	SELL Open market or private sale	$125,250 $25.05 p/Share	5,000 Reduced 3.61%	133,437 Common Stock
Jul 11 2022	SELL Open market or private sale	$60,000 $20.0 p/Share	3,000 Reduced 2.12%	138,436 Common Stock
Jun 18 2021	SELL Open market or private sale	$367,875 $29.43 p/Share	12,500 Reduced 8.36%	137,080 Common Stock
Mar 18 2021	SELL Open market or private sale	$494,750 $39.58 p/Share	12,500 Reduced 7.71%	149,580 Common Stock
Dec 18 2020	SELL Open market or private sale	$332,250 $26.58 p/Share	12,500 Reduced 7.16%	162,080 Common Stock

Also insider at

CBAY

CymaBay Therapeutics, Inc. Healthcare

Eric Lefebvre

Chief Medical Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PLRX shares.

Notify only if

Value

Insider Trading

Get notified when an Pliant Therapeutics, Inc. insider buys or sells PLRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to PLIANT THERAPEUTICS, INC.

Track Activities on PLRX

Account